Position in NVS
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$204,206
+$53,289 QoQ
Shares Held
1,303
+31.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#1,309
of 1,602 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Dunhill Financial, LLC holds $6,908,274 across 15 Drug Manufacturers - General names. NVS ranks #6 (3.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PFE |
Pfizer Inc
|
113,506 | $2,733,224 | |
| 2 | ABBV |
AbbVie Inc.
|
4,061 | $1,021,910 | |
| 3 | JNJ |
Johnson & Johnson
|
3,664 | $930,546 | |
| 4 | LLY |
ELI LILLY & Co
|
730 | $875,583 | |
| 5 | AMGN |
Amgen Inc
|
1,716 | $621,397 | |
| 6 | NVS |
Novartis AG
This page
|
1,303 | $204,206 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
1,889 | $108,844 | |
| 8 | NVO |
Novo Nordisk A S
|
1,972 | $94,537 |
All Filings in NVS
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $204,206 | 1,303 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $150,917 | 988 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $136,077 | 987 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $127,598 | 995 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $127,665 | 1,055 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $51,280 | 460 | Shares | Sole | 2025-04-21 | |
| 2024-12-31 | $64,613 | 664 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $58,315 | 507 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $53,975 | 507 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $48,171 | 498 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $50,283 | 498 | Shares | Sole | 2024-02-12 | |
| No filing history on record for this holder in this stock. | ||||||